Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | FGF3 |
Upstream (Parents) |
---|
(<<) ARSJ → FGF3 |
(<<) DEAF1 → FGF3 |
(<<) DNM1L → FGF3 |
(<<) FOSL1 → FGF3 |
(<<) IVL → FGF3 |
(<<) NFKB2 → FGF3 |
(<<) OGFR → FGF3 |
(<<) PYGB → FGF3 |
(<<) SLC26A1 → FGF3 |
(<<) WNT10A → FGF3 |
(<<) ZNF365 → FGF3 |
Downstream (Children) |
---|
FGF3 → ALPP (>>) |
FGF3 → ALPPL2 (>>) |
FGF3 → CCNA1 (>>) |
FGF3 → CRCT1 (>>) |
FGF3 → DLX2 (>>) |
FGF3 → DOK7 (>>) |
FGF3 → EN2 (>>) |
FGF3 → EPHB6 (>>) |
FGF3 → FUT4 (>>) |
FGF3 → KREMEN2 (>>) |
FGF3 → LCE3D (>>) |
FGF3 → NEUROG3 (>>) |
FGF3 → PRKCE (>>) |
FGF3 → PRSS2 (>>) |
FGF3 → SPINK5 (>>) |
FGF3 → TGFA (>>) |
FGF3 → WNT5B (>>) |
FGF3 → ZSCAN10 (>>) |